


{"id":8158,"date":"2026-05-28T11:07:05","date_gmt":"2026-05-28T11:07:05","guid":{"rendered":"https:\/\/www.viamedsalud.com\/ivoqa\/?p=8158"},"modified":"2026-05-28T11:10:31","modified_gmt":"2026-05-28T11:10:31","slug":"ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac","status":"publish","type":"post","link":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/","title":{"rendered":"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC"},"content":{"rendered":"<p>The IVOQA team at the Hospital Universitario Viamed Santa Elena has published a pioneering study focused on developing new strategies to expand access to advanced treatments for patients with peritoneal carcinomatosis.<\/p>\n<p><a href=\"https:\/\/www.ejso.com\/article\/S0748-7983(26)00489-0\/fulltext\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-8156 size-full\" src=\"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/ESTUDIO-PIONERO-PIPAC-.jpg\" alt=\"\" width=\"606\" height=\"204\" srcset=\"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/ESTUDIO-PIONERO-PIPAC-.jpg 606w, https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/ESTUDIO-PIONERO-PIPAC--300x101.jpg 300w\" sizes=\"(max-width: 606px) 100vw, 606px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>The Challenge of the &#8220;Inaccessible Abdomen&#8221;: How to Expand Access to the PIPAC Technique?<\/strong><\/h2>\n<p>The study, titled <em>&#8220;Ultrasound-guided Preoperative Progressive Pneumoperitoneum to Facilitate Pressurized Intraperitoneal Aerosol Chemotherapy in Inoperable Peritoneal Carcinomatosis,&#8221;<\/em> addresses one of the main technical limitations of PIPAC (pressurized intraperitoneal aerosol chemotherapy): the so-called &#8220;inaccessible abdomen.&#8221; This condition affects approximately 5% of patients with peritoneal carcinomatosis due to extensive abdominal adhesions resulting from previous surgeries.<\/p>\n<p>The prospective study evaluated the feasibility and safety of ultrasound- and hydrodissection-guided preoperative progressive pneumoperitoneum (PPP) in five patients with inoperable peritoneal carcinomatosis and previously inaccessible abdomens. Thanks to this technique, all inaccessible abdomens were successfully converted into accessible ones, allowing for the safe administration of PIPAC or ePIPAC in 100% of cases, with zero procedure-related complications.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Study Results and SERAM Recognition for Oncological Advancement<\/strong><\/h2>\n<p>This publication represents a significant breakthrough in peritoneal oncology, as it offers a practical and reproducible solution for patients who, until now, were excluded from advanced intraperitoneal therapies due to the inability to achieve safe laparoscopic access.<\/p>\n<p>Furthermore, this work was honored with the <strong>&#8220;Merit Award&#8221;<\/strong> by SERAM (<em>Sociedad Espa\u00f1ola de Radiolog\u00eda M\u00e9dica<\/em> \/ Spanish Society of Medical Radiology) during its 38th Congress, highlighting the innovation and multidisciplinary approach of the project.<\/p>\n<p>The research involved Dr. Delia Cort\u00e9s Guiral, Jose Maria Abadal Villayandre, Dr. Natalia Echegaray Nu\u00f1ez, Esther G\u00e1lvez, and Dr. Carlota Pardo Garc\u00eda, reinforcing IVOQA&#8217;s commitment to clinical research and the development of new therapeutic strategies for advanced peritoneal carcinomatosis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The IVOQA team at the Hospital Universitario Viamed Santa Elena has published a pioneering study focused on developing new strategies to expand access to advanced treatments for patients with peritoneal carcinomatosis. &nbsp; The Challenge of the &#8220;Inaccessible Abdomen&#8221;: How to Expand Access to the PIPAC Technique? The study, titled &#8220;Ultrasound-guided Preoperative Progressive Pneumoperitoneum to Facilitate [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":8154,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[60],"tags":[],"class_list":["post-8158","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-scientific-activity"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC - IVOQA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC - IVOQA\" \/>\n<meta property=\"og:description\" content=\"The IVOQA team at the Hospital Universitario Viamed Santa Elena has published a pioneering study focused on developing new strategies to expand access to advanced treatments for patients with peritoneal carcinomatosis. &nbsp; The Challenge of the &#8220;Inaccessible Abdomen&#8221;: How to Expand Access to the PIPAC Technique? The study, titled &#8220;Ultrasound-guided Preoperative Progressive Pneumoperitoneum to Facilitate [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/\" \/>\n<meta property=\"og:site_name\" content=\"IVOQA\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T11:07:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-28T11:10:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/EJSO-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"viadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"viadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/\"},\"author\":{\"name\":\"viadmin\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#\\\/schema\\\/person\\\/4c39b59ca8db0f2e7fe6cf0323bd17d4\"},\"headline\":\"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC\",\"datePublished\":\"2026-05-28T11:07:05+00:00\",\"dateModified\":\"2026-05-28T11:10:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/\"},\"wordCount\":292,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/EJSO-logo.jpg\",\"articleSection\":[\"Scientific activity\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/\",\"name\":\"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC - IVOQA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/EJSO-logo.jpg\",\"datePublished\":\"2026-05-28T11:07:05+00:00\",\"dateModified\":\"2026-05-28T11:10:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/EJSO-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/EJSO-logo.jpg\",\"width\":400,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"IVOQA\",\"item\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scientific activity\",\"item\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/scientific-activity\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/\",\"name\":\"IVOQA\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#organization\"},\"alternateName\":\"Instituto Viamed de Oncolog\u00eda Quir\u00fargica Avanzada\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#organization\",\"name\":\"IVOQA\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/cropped-Recurso-3.png\",\"contentUrl\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/cropped-Recurso-3.png\",\"width\":896,\"height\":256,\"caption\":\"IVOQA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#\\\/schema\\\/person\\\/4c39b59ca8db0f2e7fe6cf0323bd17d4\",\"name\":\"viadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g\",\"caption\":\"viadmin\"},\"sameAs\":[\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC - IVOQA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/","og_locale":"en_US","og_type":"article","og_title":"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC - IVOQA","og_description":"The IVOQA team at the Hospital Universitario Viamed Santa Elena has published a pioneering study focused on developing new strategies to expand access to advanced treatments for patients with peritoneal carcinomatosis. &nbsp; The Challenge of the &#8220;Inaccessible Abdomen&#8221;: How to Expand Access to the PIPAC Technique? The study, titled &#8220;Ultrasound-guided Preoperative Progressive Pneumoperitoneum to Facilitate [&hellip;]","og_url":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/","og_site_name":"IVOQA","article_published_time":"2026-05-28T11:07:05+00:00","article_modified_time":"2026-05-28T11:10:31+00:00","og_image":[{"width":400,"height":400,"url":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/EJSO-logo.jpg","type":"image\/jpeg"}],"author":"viadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"viadmin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/#article","isPartOf":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/"},"author":{"name":"viadmin","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#\/schema\/person\/4c39b59ca8db0f2e7fe6cf0323bd17d4"},"headline":"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC","datePublished":"2026-05-28T11:07:05+00:00","dateModified":"2026-05-28T11:10:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/"},"wordCount":292,"commentCount":0,"publisher":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#organization"},"image":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/#primaryimage"},"thumbnailUrl":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/EJSO-logo.jpg","articleSection":["Scientific activity"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/","url":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/","name":"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC - IVOQA","isPartOf":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/#primaryimage"},"image":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/#primaryimage"},"thumbnailUrl":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/EJSO-logo.jpg","datePublished":"2026-05-28T11:07:05+00:00","dateModified":"2026-05-28T11:10:31+00:00","breadcrumb":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/#primaryimage","url":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/EJSO-logo.jpg","contentUrl":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2026\/05\/EJSO-logo.jpg","width":400,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/ivoqa-develops-new-strategy-to-treat-patients-previously-excluded-from-pipac\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"IVOQA","item":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/"},{"@type":"ListItem","position":2,"name":"Scientific activity","item":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/scientific-activity\/"},{"@type":"ListItem","position":3,"name":"IVOQA Develops New Strategy to Treat Patients Previously Excluded from PIPAC"}]},{"@type":"WebSite","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#website","url":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/","name":"IVOQA","description":"","publisher":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#organization"},"alternateName":"Instituto Viamed de Oncolog\u00eda Quir\u00fargica Avanzada","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#organization","name":"IVOQA","url":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2022\/09\/cropped-Recurso-3.png","contentUrl":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2022\/09\/cropped-Recurso-3.png","width":896,"height":256,"caption":"IVOQA"},"image":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#\/schema\/person\/4c39b59ca8db0f2e7fe6cf0323bd17d4","name":"viadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g","caption":"viadmin"},"sameAs":["https:\/\/www.viamedsalud.com\/ivoqa"]}]}},"_links":{"self":[{"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/posts\/8158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/comments?post=8158"}],"version-history":[{"count":2,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/posts\/8158\/revisions"}],"predecessor-version":[{"id":8161,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/posts\/8158\/revisions\/8161"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/media\/8154"}],"wp:attachment":[{"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/media?parent=8158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/categories?post=8158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/tags?post=8158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}